Neurosteroids have been implicated as a factor that increases subjective effects of alcohol (Ray et al. 2010). Carriers of the 118G allele displayed increased neurosteroid levels after NTX treatment, suggesting that GABAergic neurosteroids may be a useful adjunctive therapy for alcoholism in non-carriers of the 118G allele associated with therapeutic efficacy to NTX (Ray et al. 2010).
